How methicillin-resistant Staphylococcus aureus evade neutrophil killing

Current Opinion in Hematology

Volumn 22, Issue 1, 2015, Pages 30-35

  Greenlee Wacker, Mallary ^a,b,c   DeLeo, Frank R ^d   Nauseef, William M ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytolysis; Inflammation; Necroptosis; Staphylococcal infection

Indexed keywords

REACTIVE OXYGEN METABOLITE; TOXIN;

BACTERIAL VIRULENCE; CELL KILLING; CYTOLYSIS; HOST RESISTANCE; HUMAN; INFLAMMATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROORGANISM; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; REVIEW; ANIMAL; CHEMOTAXIS; IMMUNE EVASION; IMMUNOLOGY; PATHOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALS; CHEMOTAXIS; HUMANS; IMMUNE EVASION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHILS; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 84916938319     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000096     Document Type: Review

References (54)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-1771.
2. Coombs GW, Pearson JC, O'Brien FG, et al. Methicillin-resistant Staphylo-coccus aureus clones, Western Australia. Emerg Infect Dis 2006; 12:241-247.
3. Dantes R, Mu Y, Belflower R, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013; 173:1970-1978.
4. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005; 41 (Suppl 4):S269-S272.
5. Diekema DJ, Richter SS, Heilmann KP, et al. Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study. Infect Control Hosp Epidemiol 2014; 35:285-292.
6. Rogers DE, Tompsett R. The survival of staphylococci within human leuko cytes. J Exp Med 1952; 95:209-230.
7. DeLeo FR, Nauseef WM. Granulocytic phagocytes. In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 8th ed Philadelphia, PA: Elsevier/Saunders; 2014 (in press).
8. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007; 219:88-102.
9. Rigby KM, DeLeo FR. Neutrophils in innate host defense against Staphylo-coccus aureus infections. Semin Immunopathol 2012; 34:237-259.
10. Bratton DL, Henson PM. Neutrophil clearance: when the party is over, cleanup begins. Trends Immunol 2011; 32:350-357.
11. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7:678-689.
12. Spaan AN, Surewaard BG, Nijland R, van Strijp JA. Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu Rev Microbiol 2013; 67:629-650.
13. Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol 2014; 17:32-37.
14. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-3919.
15. Greenlee-Wacker MC, Rigby KM, Kobayashi SD, et al. Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage effer-ocytosis and induces programmed necrosis. J Immunol 2014; 192:4709-4717.
16. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80:1550-1560.
17. Schwartz J, Leidal KG, Femling JK, et al. Neutrophil bleaching of GFP-expressing staphylococci: probing the intraphagosomal fate of individual bacteria. J Immunol 2009; 183:2632-2641.
18. Weinrauch Y, Abad C, Liang NS, et al. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. J Clin Invest 1998; 102:633-638.
19. Weinrauch Y, Elsbach P, Madsen LM, et al. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996; 97:250-257.
20. Femling JK, Nauseef WM, Weiss JP. Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospho-lipids of Staphylococcus aureus ingested by human neutrophils. J Immunol 2005; 175:4653-4661.
21. Rosen H. Editorial: of mice and men-yet again. JLeukoc Biol 2013; 94:210-212.
22. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731-2738.
23. Loffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010; 6:e1000715.
24. Kim HK, Missiakas D, Schneewind O. Mouse models for infectious diseases caused by Staphylococcus aureus. J Immunol Methods 2014; 410:88-99.
25. Palazzolo-Ballance AM, Reniere ML, Braughton KR, et al. Neutrophil micro-bicides induce a pathogen survival response in community-associated methi-cillin-resistant Staphylococcus aureus. J Immunol 2008; 180:500-509.
26. Mandell GL. Catalase, superoxide dismutase, and virulence of Staphylococ-cus aureus. In vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. J Clin Invest 1975; 55:561-566.
27. Malachowa N, Kohler PL, Schlievert PM, et al. Characterization of a Staphy-lococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis. Infect Immun 2011; 79:342-352.
28. Liu GY, Essex A, Buchanan JT, et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 2005; 202:209-215.
29. Clauditz A, Resch A, Wieland KP, et al. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 2006; 74:4950-4953.
30. Park B, Nizet V, Liu GY. Role of Staphylococcus aureus catalase in niche competitionagainstStreptococcuspneumoniae.JBacteriol2008; 190:2275-2278.
31. Weissbach H, Resnick L, Brot N. Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage. Biochim Biophys Acta 2005; 1703:203-212.
32. Ezraty B, Aussel L, Barras F. Methionine sulfoxide reductases in prokaryotes. Biochim Biophys Acta 2005; 1703:221-229.
33. Rosen H, Klebanoff SJ, Wang Y, et al. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proc Natl Acad Sci USA 2009; 106:18686-18691.
34. Pang YY, Schwartz J, Bloomberg S, et al. Methionine sulfoxide reductases protect against oxidative stress in Staphylococcus aureus encountering exogenous oxidants and human neutrophils. J Innate Immun 2014; 6:353-364.
35. Barrett JF, Hoch JA. Two-component signal transduction as a target for microbial antiinfective therapy. Antimicrob Agents Chemother 1998; 42: 1529-1536.
36. Voyich JM, Vuong C, DeWald M, et al. The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis 2009; 199:1698-1706.
37. Flack CE, Zurek OW, Meishery DD, et al. Differential regulation of staphy-lococcal virulence by the sensor kinase SaeS in response to neutrophil-derived stimuli. Proc Natl Acad Sci USA 2014; 111:E2037-E2045.
38. Benson MA, Lilo S, Nygaard T, et al. Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins. J Bacteriol 2012; 194:4355-4365.
39. Olson ME, Nygaard TK, Ackermann L, et al. Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor. Infect Immun 2013; 81:1316-1324.
40. Ventura CL, Malachowa N, Hammer CH, et al. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteo-mics. PLoS One 2010; 5:e11634.
41. DuMont AL, Yoong P, Surewaard BG, et al. Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect Immun 2013; 81:1830-1841.
42. Pang YY, Schwartz J, Thoendel M, et al. agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2010; 2:546-559.
43. Surewaard BG, de Haas CJ, Vervoort F, et al. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol 2013; 15:1427-1437.
44. Grosz M, Kolter J, Paprotka K, et al. Cytoplasmic replication of Staphylo-coccus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell Microbiol 2014; 16:451-465.
45. Forsman H, Christenson K, Bylund J, Dahlgren C. Receptor-dependent and-independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species. Infect Immun 2012; 80: 1987-1995.
46. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6:1191-1197.
47. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, et al. Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2010; 2:560-575.
48. DuMont AL, Yoong P, Day CJ, et al. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci USA 2013; 110:10794-10799.
49. Graves SF, Kobayashi SD, Braughton KR, et al. Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol 2012; 92:361-374.
50. Holzinger D, Gieldon L, Mysore V, et al. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J Leukoc Biol 2012; 92:1069-1081.
51. Craven RR, Gao X, Allen IC, et al. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 2009; 4:e7446.
52. Munoz-Planillo R, Franchi L, Miller LS, Nunez G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 2009; 183:3942-3948.
53. Bakele M, Joos M, Burdi S, et al. Localization and functionality of the inflammasome in neutrophils. J Biol Chem 2014; 289:5320-5329.
54. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38:209-223.